Itamar Poran
Overview
Explore the profile of Itamar Poran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drozdinsky G, Arad N, Spectre G, Livneh N, Poran I, Raanani P, et al.
Thromb Res
. 2024 Feb;
235:92-97.
PMID: 38308884
Introduction: Atrial fibrillation or flutter (AF) is prevalent in cancer patients. Many of these patients have an indication for anticoagulation (AC) but are also at risk for developing chemotherapy-induced thrombocytopenia....
2.
Poran I, Mokh A, Vronsky D, Drozdinsky G, Basharim B, Eliakim-Raz N
Med Clin (Barc)
. 2023 May;
161(2):59-61.
PMID: 37248130
Introduction: Initiation of global vaccination significantly reduced the morbidity and mortality of COVID-19. During the Omicron wave, approximately 70% of the Israeli adult population was fully vaccinated, but the efficacy...
3.
Daitch V, Turjeman A, Poran I, Tau N, Ayalon-Dangur I, Nashashibi J, et al.
Trials
. 2022 Dec;
23(1):1038.
PMID: 36539814
Background: Although regulatory changes towards correcting the underrepresentation of women in randomized controlled trials (RCTs) occurred (National Institutes of Health 1994), concerns exist about whether an improvement is taking place....
4.
Turjeman A, Koppel F, Franceschini E, Yahav D, Dolci G, Bacca E, et al.
Gerontology
. 2022 Oct;
69(3):312-320.
PMID: 36273449
Introduction: Reports regarding the external validity of randomized controlled trials (RCTs) are scarce. We aimed to assess the population external validity of an investigator-initiated RCT on the duration of antibiotics...
5.
Turjeman A, Wirtheim E, Poran I, Leibovici L
Clin Microbiol Infect
. 2022 Aug;
29(1):111.e1-111.e4.
PMID: 36031054
Objectives: Estimating the isolated effect of coronavirus disease 2019 (COVID-19) on the risk of mortality is challenging. We aimed to determine whether COVID-19 was associated with high rates of mortality...
6.
Poran I, Elbaz M, Turjeman A, Samuel M, Eliakim-Raz N, Nashashibi J, et al.
Antibiotics (Basel)
. 2022 Jun;
11(6).
PMID: 35740219
Background: The rise of multi-drug-resistant pathogens and nosocomial infections among hospitalized patients is partially attributed to the increased use of antibiotic therapy. A prediction model for in-hospital antibiotic treatment could...
7.
Gentilotti E, De Nardo P, Cremonini E, Gorska A, Mazzaferri F, Canziani L, et al.
Clin Microbiol Infect
. 2021 Oct;
28(1):13-22.
PMID: 34601148
Background: Point-of-care tests could be essential in differentiating bacterial and viral acute community-acquired lower respiratory tract infections and driving antibiotic stewardship in the community. Objectives: To assess diagnostic test accuracy...
8.
Turjeman A, Poran I, Daitch V, Tau N, Ayalon-Dangur I, Nashashibi J, et al.
J Clin Epidemiol
. 2021 Sep;
140:125-134.
PMID: 34517102
Objective: to characterize randomized controlled trials (RCTs) that did not report the overall number of participants assessed for eligibility and to identify factors associated with higher enrollment rates. Study Design...
9.
Porat Y, Nashashibi J, Poran I, Paul M
Open Forum Infect Dis
. 2021 Aug;
8(8):ofab373.
PMID: 34395711
Background: Short-term readmission is an important outcome reflecting the poor trajectory of sepsis survivors. The aim of this study was to identify the major risk factors for 30-day readmission among...
10.
Ghantous N, Hershkovic S, Poran I, Benninger F, Molad Y, Eliakim-Raz N
Harefuah
. 2021 May;
160(5):307-310.
PMID: 34028223
Neurologic symptoms are an extremely rare presentation of Kikuchi-Fujimoto disease. We report a case of a young female patient diagnosed with Kikuchi-Fujimoto disease, presenting with neurologic symptoms compatible with aseptic...